1 and the main component of severe morbidity [2] [3] [4] [5] , jeopardizing the woman's fertility, 3 exposing her to risks of transfusion and intensive care, and incurring costs. From reports in 4 developed countries, about one percent of deliveries are associated with severe PPH [3] [4] [5] [6] . 5
Decreasing the prevalence of severe PPH remains challenging. This appears all the more 6 important given the recent increase in the incidence of PPH reported in several developed 7 countries 2, 7, 8 . Individual risk factors have been described but they poorly predict the 8 occurrence of PPH 9, 10 . Interest has focused on care-processes as they are potentially 9 amenable to change. Studies of maternal deaths show that most deaths due to PPH involve 10 delayed and substandard care in the diagnosis and management of haemorrhage [11] [12] [13] . Similar 11 findings were drawn from a population-based study of severe non-lethal PPH 14 . 12
Delay in diagnosis and treatment of PPH may result from an underestimation of blood loss at 13 delivery. Assessment of post-partum blood loss, particularly following vaginal birth, is 14 recognised as difficult. Many studies demonstrate that visual estimates of peripartum blood 15 loss are frequently inaccurate [15] [16] [17] [18] [19] [20] [21] , showing an overestimation of blood loss at low volumes 16 and an underestimation at larger volumes, the magnitude of underestimation typically 17 increasing with the volume of haemorrhage. 18 The hypothesis of this study was that if blood loss is monitored and objectively measured by 19 collection in a transparent plastic bag, rather than being visually assessed, care-giver response 20 will be triggered more rapidly when excessive blood loss occurs. Specifically when bleeding 21 is excessive but before haemorrhage has become catastrophic, appropriate management will 22 take place without delay, so reducing the incidence of severe PPH. A preliminary study shows 23 that a plastic collector bag constitutes a simple instrument to diagnose haemorrhage in the 24 delivery room 22 . However, the impact of its use on PPH-related health outcomes has never 25 been tested. Despite lacking evidence, the bag is routinely used in a significant proportion of 1 maternity units in Belgium, France, Italy, and Portugal (Euphrates survey 23 , unpublished data). 2
The objective of this trial was to evaluate the effectiveness of the systematic use of a 3 transparent plastic collector bag for measurement of postpartum blood loss after vaginal 4 delivery in reducing the incidence of severe PPH. 5 6
Methods

7
Trial design 8
A cluster-randomised design with maternity unit was the unit of randomization. Given the 9 logistics of clinical practice on the delivery suite, contamination appeared to be inevitable in 10 an individual-patient randomised trial setting. 11
Setting 12
The sites selected for the trial comprised 78 maternity units in 13 European countries (see 13 Table1). 14
Participants 15
Maternity units 16
Maternity units were eligible if they had more than 200 vaginal deliveries annually (excluding 17 water births), and no previous policy of routine use of collector bags. In addition, to ensure 18 that the standard of care for management of the third stage of labour was similar across all 19 participating units, they had to comply with the EUPHRATES consensus statement on the 20 prevention and management of PPH 24 ; a minimum standard, not a detailed guideline. 21
Women 22
In all maternity units of participating countries (except Denmark), all women undergoing a 23 vaginal delivery during the study period were included. In Denmark, enrolment into the study 24 in each maternity unit was midwife-dependant; if a midwife agreed to participate, all his/her 1 vaginal deliveries were included. 2 3
Randomization 4
The random allocation was produced centrally by the National Perinatal Epidemiology Unit in 5
Oxford, UK. A stratified design was used to ensure that the two arms of the trial were as 6 similar as possible at baseline with respect to the stratification factors (i) country and (ii) size 7 of maternity unit (median split within country). 8
Maternity units were randomly allocated to either systematically use a collector bag after 9
vaginal delivery (intervention arm), or not use the bag (control group). 10 11
Intervention 12
The trial was implemented between January 2006 and May 2007, depending on the country. 13
Prior to participation, each centre was visited by the national coordinator. At the visit, staff 14 were reminded of the EUPHRATES consensus statement on the prevention and management 15 of PPH and familiarised with the processes and the data collection instrument. 16 In the intervention group, a second visit from the national coordinator took place after 17 randomisation, during which, use of the collector bag was explained to birth attendants with 18 standard written instructions and a training video aid. The bag was to be placed under the 19 pelvis of the mother as soon as the baby was born and before delivery of the placenta. It was 20 transparent and graduated, allowing continuous monitoring of blood loss. It did not require 21 sterilization and could be used in dorsal, lateral or lithotomy positions. Women delivering 22 standing or crouching could be offered the opportunity to lie down for the third stage, 23 allowing the bag to be placed under their pelvis. The bag was to be left under the woman's 24 buttocks until the birth attendant was no longer concerned about blood loss e.g. when the 25 sanitary towel was applied to the vulva. Bags were purchased centrally and provided to each 1 cluster in the intervention arm. 2
In the control group, no collector bag was used, postpartum blood loss being visually assessed. 3
During the study period, use of collector devices was monitored to assess compliance with 4 allocation. 5 6
Outcomes 7
The primary outcome for the trial was the incidence of severe PPH following vaginal 8 deliveries, defined as a composite of all women who experienced one or more of the 9 following: blood transfusion, intravenous plasma expansion, arterial embolisation, surgical 10 procedure, admission to intensive care unit, treatment with recombinant factor VII and death. 11
Secondary outcomes were each of the components of the primary outcome, manual removal 12 of the placenta and administration of prostaglandins after delivery. 13 
14
Data collection 15
Each participating centre was asked to collect data from all women undergoing a vaginal 16 delivery for a period of 4 months. 17
Data were collected during two time intervals: a 1-month period pre-randomisation (baseline 18 period), and a 3-month period beginning immediately following randomisation in the control 19 group (trial period). In the intervention group, the 3-month period of data collection followed 20 a 2-week training period during which the unit started using the collector bag on women 21 undergoing vaginal delivery. 22
Data were collected using a form filled in by the birth attendants for each vaginal delivery, 23 and included information on the woman's age, induction of labour, mode of delivery, number 24 of babies and birth weight, prophylactic uterotonics, and outcome data. Additionally, a second 25 form was used for deliveries where severe PPH occurred, collecting detailed information 1 regarding delivery and PPH management. This form was used to cross-check criteria for the 2 primary outcome. 3 
4
Sample size 5
Sample size calculation took into account the cluster-randomised design; the intracluster 6 correlation coefficient was estimated to be 0.01. Assuming an event rate for the primary 7 outcome of 2.5% in the control group, in order to detect a decrease in the event rate to 1.5% (a 8 40% relative risk reduction) with 80% power, a 2-sided significance level of 5% and an 9 average cluster size of 300 women, 82 clusters (41 in each arm of the trial) were required 25 . 10
11
Statistical analysis 12
Participants/maternity units were analysed in the groups to which they were assigned 13 regardless of the management received by individual women or deviation from the protocol. Individual woman level analysis -primary and secondary outcomes were compared between 23 the two study groups both unadjusted and adjusted for the effect of clustering. In order to 24 determine the magnitude and direction of any differences in outcomes between the two 25 groups, crude odds ratios and 95% confidence intervals were calculated. Furthermore, logistic 1 regression was used to adjust for clustering and key prognostic factors. The cluster 2 randomised design imparts a data structure that facilitates the calculation of a valid 3 intracluster correlation coefficient, ρ. 4
Cluster level analysis was only performed on the primary outcome. Some hospitals 5 contributed fewer events than others, and some recruited fewer women. We allowed these 6 hospitals to have less effect on the treatment estimate by weighting the analysis based on the 7 precision, i.e. calculating the weighted mean difference for the treatment comparison. A 8 weighted linear regression model was used to test the effect of the intervention on the rate of 9
severe PPH during the trial period, adjusting for the baseline rate, expressed as the weighted 10 mean difference (plus 95% confidence interval). 11
12
Ethical aspects 13
Ethics approval was obtained in each country from relevant local or national research ethics 14 committees. Consent to participate was taken from the maternity units. Because the procedure 15 being tested was not invasive or different from current clinical practice, and because outcome 16 data were routinely collected at maternity units and anonymously transmitted, no individual 17 consent was sought. 18
Role of the funding source 20
The project was funded by the European Union (EU) under Framework 5 (contract QLG4-21
CT-2001-01352). EU had no role in the design, management, data collection, analyses, or 22 interpretation of the data. EU had no role in the writing of the manuscript or in the decision to 23 submit for publication. 24 1 Figure 1 shows the flow of maternity units and women through the study. Of the 84 maternity 3 units meeting the inclusion criteria, two maternity units declined to participate before 4 allocation. Forty one maternity units were randomised to the intervention group and 41 to the 5 control group. Two maternity units in each group opted out before receiving notification of 6 allocation because they lacked the necessary resources. Thirty-nine maternity units in each 7 group completed the trial. Table 1 shows the number of participating maternity units and 8 women included in each country. 9
Results
2
One maternity unit did not collect baseline data in the intervention group. Deviating from the 10 protocol, the majority of maternity units (31 of 39) continued collecting data during the 2-11 week training period in the intervention arm. In these units, trial data collection started after 12 the first month of baseline data collection. Four units in the control group collected trial data 13 for more than 3 months (up to 5 months). Only the 3-month period of data collection specified 14 in the protocol was considered for all units. In some Austrian hospitals, the number of women 15 included was low, given the total expected number of deliveries. The national coordinator 16 confirmed that the missing data were all caesarean deliveries, and that in some hospitals the 17 caesarean rate was very high. Nevertheless, sensitivity analyses were performed, and showed 18 that excluding these hospitals or even the entire Austrian data set did not influence the results. 19 
20
Characteristics of maternity units and women 21
Baseline data were collected for 4937 in the intervention group and 4758 vaginal deliveries in 22 the control group and characteristics of maternity units and women (Table 2) were broadly 23 similar in the two groups for all factors, except for manual removal of the placenta and 24 prophylactic uterotonics, which were more common among women in the intervention group. 25
Primary outcome 1
Individual level analysis 2
A total of 25381 women were included in the analysis (11037 in the intervention group and 3 14344 in the control group). The greater number of women in the control group was due to a 4 larger median cluster size (241 and 284 in the intervention and control groups, respectively).. 5
The incidence of severe PPH was 189 out of 11037 of vaginal deliveries (1.71%) in the 6 intervention group compared to 295 out of 14344 in the control group (2.06%). The difference 7
was not statistically significant ( Table 3 ). The crude odds ratio for the effect of the 8 intervention was 0.83 (95% CI, 0.69 to 1.00). The odds ratio adjusted for clustering was 0.83 9 (95% CI, 0.27 to 2.60); after further adjustment for age, prophylactic uterotonics in the third 10 stage, mode of delivery and birth weight, the odds ratio was 0.82 (95% CI, 0.26 to 2.53). 11
Sensitivity analyses were conducted to test the robustness of this result excluding units 12 deviating from the protocol, and also by country, and by baseline rate of severe PPH (median 13 split by country); these analyses provided similar results. 14
Cluster level analysis 15
The weighted mean severe PPH rate was 1.71% (SD 2.51) in the intervention group and 16 2.06% (SD 3.52) in the control group. The intracluster correlation coefficient for severe PPH 17 was 0.023. There was no significant difference in the rate of severe PPH between the two 18 groups (weighted mean difference -0.34%, (-2.56% to 1.87%); p=0.75). Adjusting for the 19 baseline rate of severe PPH resulted in a slight change in this result (adjusted weighted mean 20 difference 0.16%, (-0.69% to 1.02%); p=0.70). Rates of severe PPH in the baseline and trial 21 periods for each maternity unit were heterogeneous across units in different countries ( Figure  22 2). 23 Figure 3 shows the difference in baseline and trial rates of severe PPH for each unit in the 24 intervention group, according to the compliance of bag usage. There was no relationship 25 between the difference in severe PPH rates (baseline and trial) and the actual proportion of 1 bag use. The analysis of the intervention effect on the primary outcome, including in the 2 intervention arm only maternity units where the bag was used in at least 50% of vaginal 3 deliveries, showed no significant difference between the two groups (individual level analysis 4 adjusting for cluster and individual characteristics; adjusted OR 0.59, 95% CI (0.23-1.53)). 5 6
Secondary outcomes (individual level analysis) 7
Analyses were performed to test the effect of the intervention on the main components of the 8 primary outcome (Table 3 ). The proportion of blood transfusion, surgical procedure or 9 embolisation and of manual removal of placenta, did not substantially differ between the 10 intervention and control groups, whether after adjusting for cluster or after further adjusting 11 for other prognostic factors. There were no maternal deaths. 12
The proportions of receipt of intravenous plasma expanders and of prostaglandins use were 13 different between intervention and control groups, but the differences were not significant 14 after adjusting for clustering effect. 15 
16
Discussion
17
Strengths and limitations of study 18
In this cluster randomised trial conducted on 25381 vaginal deliveries in 78 maternity units of 19 13 European countries, the systematic use of a collector bag after vaginal delivery did not 20 modify the rate of severe forms of postpartum haemorrhage. There was no evidence of 21 heterogeneity, the results not differing according to country or size of hospital. 22
This trial provides new results on an unexplored although controversial aspect of care in the third 23 stage of labour. Although objective measurement has been shown to increase the accuracy of 24 postpartum blood loss assessment compared to visual estimation [15] [16] [17] [18] [19] [20] [21] , the routine use of a collector 25 bag is not associated with a significant decrease in severe PPH. This result constitutes an important 1 contribution to the on-going debate on strategies to improve the care of women with PPH and 2 decrease the incidence of severe cases. 3
Additionally, the cluster-randomised design, the large number of clusters and their diversity 4 provide good external validity to this trial. 5
There were small deviations from the protocol for data collection, but sensitivity analyses showed 6 that none of these changed the internal validity of the trial. 7
There was large heterogeneity of baseline rates for the severe event between units (0 to 13.4 %). In 8 theory, such a variation should be an asset, and reflect a broad range of levels of risk in the 9 participating maternity units. However, because these differences were strongly related to the 10 country, there remains some concern regarding the criteria in use for the management of PPH in 11 different parts of Europe. Again sensitivity analysis showed that this aspect did not alter the 12
results. 13
There was some heterogeneity in baseline data between the intervention and control groups. 14 Heterogeneity in PPH-related practices and PPH rates has been reported across maternity 15 units in Europe, both between and within countries 4, 23 . Although randomization is expected 16 to balance these differences between the two arms, the number of units randomized, although 17 large for a cluster RCT, makes residual imbalance possible although probably very slight. 18
However, analyses were adjusted for the main determinants of PPH (individual level analysis), 19 and baseline rate of severe PPH (cluster-level analysis); in addition, sensitivity analysis 20 indicated that the absence of significant impact of the intervention was similar whether the 21 maternity units had high or low baseline rate of severe PPH. In consequence, any perceived or 22 real imbalance in these characteristics should have little or no impact on the findings. 23 
24
Hypotheses for the results 25
Different mechanisms may explain the absence of difference in the rates of severe PPH between 1 maternity units which used the bag and those where blood loss was visually assessed. 2 This may be due to a lack of compliance to the intervention. However, the persistent absence 3 of difference between the 2 groups when the analysis was restricted to the units where the bag 4 was used in a high proportion of deliveries suggests this is unlikely. 5
One potential reason for the apparent ineffectiveness of the intervention might be that the 6 bags were actually not used correctly; in particular, there might be concern that the bags were 7 covered most of the time and thus could not be viewed. However, because detailed oral and 8 written instructions were provided and the training video clearly showed the care giver 9
watching the bag and the graduations, such misuse is unlikely to explain the observed lack of 10 effect. 11
Participation in the study may indicate a particular interest in the management of PPH so that 12 existing management had little room for improvement. However, the variety of baseline rates 13 of severe PPH in these units makes such a selection process unlikely. 14 It may be hypothesized that the intervention has a double effect, in two opposite directions: 15 increasing the rate of ascertainment through increased vigilance and decreasing the prevalence rate 16 through timely management of excessive bleeding. If these two components were of the same 17 order of magnitude, the global effect would be no effect. However, if this explanation was 18 realistic, one would expect different size of effects with different baseline rates and/or different 19 degrees of compliance. None of this occurred, making it unlikely that a benefit of the intervention 20 in terms of decreased severe outcome was balanced by an equivalent increase in ascertainment. In 21 fact the intervention appeared to increase PPH rates, reflecting possibly, that the intervention was 22 more effective on improving ascertainment than on changing practice. 23 A concomitant effect in the control group may also have contributed to the absence of 24 difference between the two arms. Contamination of the intervention to control units is 25 unlikely since participating units were not in contact, and no use of bags was reported in any 1 control unit. Participation in a research study, independently of any specific intervention, has 2 been reported to change behaviors of participants (Hawthorne effect 26 ). The hypothesis that 3 the management of PPH would have improved in the control arm is, however, not supported 4 by the absence of change in the rate of severe PPH between the baseline and trial periods in 5 this group. 6
The most plausible explanation of the negative result of this trial is that having a more 7 accurate assessment of postpartum blood loss is not, by itself, sufficient to change behaviors 8 of care givers and improve PPH management. Lack of identification of women with excessive 9 postpartum bleeding is a considerable problem, potentially leading to higher levels of medical 10 intervention if the bleeding progresses to severe haemorrhage. We designed a strategy to 11 increase care-givers awareness. The fact that this has not translated into a change in clinical 12 outcomes probably reflects the complexity of management decisions, which are influenced by 13 multiple factors such as organization of the delivery ward, and how care givers perceive and 14 cope with emergencies. 15
Comparison with other studies 16 We did not find any other published study assessing the effectiveness of the collector bag. 17
However we have identified other large multicentre randomised trials in the field of maternal 18
and child health where a diagnostic or screening test was evaluated without any associated 19 instructions about the management of abnormal results [27] [28] [29] . None of these trials showed 20 benefit with the introduction of the test. In addition Althabe et al have shown that simple 21 information is not sufficient to impact birth attendants readiness to change 30 . These various 22 reports suggest that the effect of enhanced diagnostic methods should include an 23 accompanying protocol of management, and maybe a specific behavioral intervention, which 24 in effect becomes a "complex intervention". 25
Conclusions and policy implications 1
The practical implication of these results for high income countries, is that those units which 2 are using a collector bag (at a cost between 1 and 11 € per bag in Europe) need to reconsider 3 their practice, and maybe reallocate the resources to other aspects of care. Units which are not 4 routinely using the bag should keep the same policy. For resource poor countries positive 5 results of the use of the "kanga collector" have been reported 31 . This needs to be tested in a 6 randomised design. In the current context of reported on-going increase in the prevalence of 7 PPH, further research is needed to develop and test effective strategies to decrease the 8 prevalence of severe PPH through improvement of management. These will probably be 9 multifaceted interventions, and in this context, the collector bag may warrant further 10 investigation. 11
« What this paper adds » box 1
What is already known on this subject 2 Delay in diagnosis and initial care for postpartum hemorrhage (PPH) has been reported, and 3 may result from an underestimation of postpartum blood loss, due to the inaccuracy of visual 4 assessment. A collector bag has been proposed as a useful tool to objectively measure 5 postpartum blood loss. However, the impact of its use has never been tested. Despite lacking 6 evidence, the bag is routinely used in a significant proportion of maternity units in Europe. 7
8
What this study adds 9
Our study suggests that, for western countries, the routine use of a collector bag to objectively 10 assess postpartum blood loss after vaginal delivery, without specific guideline regarding 11 threshold and action, does not reduce the incidence of severe PPH. 12 
